PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)

CUSIP: 74019P207

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 6 signals
Share change
-3,037
SEC-reported price per share
$6.26
Number of holders
11
Value change
-$23,811
Number of buys
4
Number of sells
4
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
27,643,000

Security key

74019P207

Report period

Q3 2026

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Octagon Capital Advisors LP
Disclosed value leader
Aberdeen Group plc
Comparable rows
9/15
Latest evidence
21 Aug 2026
13F 13D/G 3/4/5 Lead comparable stake: 10% 6 rows are not safely comparable across share classes. 13D/G row: Octagon Capital Advisors LP Showing 1-6 of 15 holder rows.

Quick read

Octagon Capital Advisors LP leads the comparable SEC ownership view at 10%.

9 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Octagon Capital Advisors LP's linked filing trail.
Comparable ownership Top 5
Octagon Capital Advisors LP 10%
Readout Capital, LP 9.4%
Aberdeen Group plc 8.9%
Bleichroeder LP 8.2%
Lynx1 Capital Management LP 5.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Octagon Capital Advisors LP
13F 13D/G
Company
10%
Reported 13D/G · 31 Dec 2025
$10,611,000
1,350,000 shares
— 30 Jun 2026
Readout Capital, LP
13D/G
Matthew Smith
9.4%
Reported 13D/G · 30 Jun 2025
$4,980,934
1,119,311 shares
+$829,645 30 Jun 2025
Aberdeen Group plc
13F 13D/G
Company
8.9%
Reported 13D/G · 31 Dec 2025
$17,529,199
2,230,178 shares
— 30 Jun 2026
Bleichroeder LP
13F 13D/G
Company
8.2%
Reported 13D/G · 31 Dec 2025
$15,862,973
2,018,190 shares
— 30 Jun 2026
Lynx1 Capital Management LP
13D/G 13F
Company
5.4%
Reported 13D/G · 13 Jul 2026
$10,951,062
1,390,611 shares
+$3,123,997 13 Jul 2026
Empery Asset Management, LP
13D/G 13F
Company
5%
Reported 13D/G · 30 Jun 2026
$10,331,129
1,314,393 shares
-$5,144,260 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
1,235
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q4 2025 Across Filers

Q4 2025 holders
67
Q3 2026 holders
11
Holder diff
-56
Investor Q4 2025 Shares Q3 2026 Shares Share Diff Share Chg % Q4 2025 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .